Home › Funds › Parkman Healthcare Partners LLC › QURE

Parkman Healthcare Partners LLC position in QURE

UNIQURE NV · Health Care

Parkman Healthcare Partners LLC reported holding 208,170 shares of QURE (UNIQURE NV) in its Q2 2026 13F filing — a position valued at US$9.6M, representing 0.98% of its reported portfolio and ranking #41 among its reported holdings. Parkman Healthcare Partners LLC has disclosed QURE holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)208.17K sh
Reported value held$9.59M
Portfolio Weight0.98%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's QURE position evolved

Parkman Healthcare Partners LLC first disclosed a stake in QURE in Q4 2024 at 275,000 shares (US$4.9M). The position peaked in Q3 2025 at 345,356 shares, worth US$20.2M. Across 7 filings, Parkman Healthcare Partners LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 208,170 shares valued at US$9.6M — an increase of 1,328 shares quarter over quarter.. Notable position changes include a 26% trim in Q1 2025 (shares rose 32% over the following quarter), a 118% increase in Q2 2025 (shares rose 319% over the following quarter), a 25% trim in Q4 2025 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 275.00K $4.86M New
Q1 2025 203.83K $2.16M Reduce
Q2 2025 443.42K $6.18M Add
Q3 2025 345.36K $20.16M Reduce
Q4 2025 257.38K $6.16M Reduce
Q1 2026 206.84K $3.38M Reduce
Q2 2026 208.17K $9.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QURE and 13F data

QURE (UNIQURE NV) is a Health Care company. 64 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QURE

All QURE fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held QURE?

Parkman Healthcare Partners LLC has disclosed QURE holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Parkman Healthcare Partners LLC's current position in QURE?

As of Q2 2026, Parkman Healthcare Partners LLC holds 208.17K shares of QURE (UNIQURE NV), valued at $9.59M, representing 0.98% of its reported portfolio and ranking #41.

Has Parkman Healthcare Partners LLC been buying or selling QURE?

In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC increased its position in QURE. The position peaked in Q3 2025 at 345.36K shares.

Which other funds hold QURE?

Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.